Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Clinical trial NCT05776134 · AVAILABLE
Trial details
- NCT number
- NCT05776134
- Sponsor
- Kite, A Gilead Company
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.